Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer
- Type
- Retraction
- Notice date
- 6/3/2024 0:00
- Journal
- Gynecologic Oncology
- Publisher
- Elsevier
- Notice DOI
- 10.1016/j.ygyno.2024.04.024
- Original paper DOI
- 10.1016/j.ygyno.2024.03.020